Marimed (MRMD) Cash from Operations (2013 - 2026)

Marimed (MRMD) has 14 years of Cash from Operations data on file, last reported at 949000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 26.6% year-over-year to 949000.0 in Q1 2026; TTM through Mar 2026 was 7351000.0, a 51.01% increase from a year earlier, with the FY2025 full-year figure at 7695000.0, up 13.41% from the prior year.
• Cash from Operations for Q1 2026 stood at 949000.0, down from 3429000.0 in the prior quarter.
• Over the last five years, Cash from Operations for MRMD reached as high as 8490000.0 in Q1 2022 and fell as low as 6261000.0 in Q2 2022.
• Historically, Cash from Operations has averaged 1802941.18 across 5 years, with a median of 1737000.0 in 2022.
• Across the five-year window, Cash from Operations plunged 157.8% in 2022 and surged 930.27% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 1737000.0 in 2022, then jumped by 86.18% to 3234000.0 in 2023, then tumbled by 112.77% to 413000.0 in 2024, then jumped by 930.27% to 3429000.0 in 2025, then sank by 72.32% to 949000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 949000.0 in Q1 2026, 3429000.0 in Q4 2025, and 2676000.0 in Q3 2025.